Morgan Stanley Maintains Underweight on HCA Healthcare, Lowers Price Target to $380
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsPrice TargetHot
Morgan Stanley analyst Craig Hettenbach maintains HCA Healthcare (NYSE:HCA) with a Underweight and lowers the price target from $425 to $380.
Morgan Stanley analyst Craig Hettenbach maintains HCA Healthcare (NYSE:HCA) with a Underweight and lowers the price target from $425 to $380.